In addition, restoring miR-16 in NSCLC cells not only inhibits key oncogenic pathways such as ERK/MAPK but also renders the cancer cells more susceptible to cisplatin and EGFR inhibitors in xenograft models [8]. The gene discussed is EGFR; the disease is cancer.